Medical Marijuana-Focused Mira Pharmaceuticals Stock Surges After Neuropsychiatric Disorders Update – Here’s Why

Mira Pharmaceuticals Inc (NASDAQ:MIRA) disclosed a discovery regarding its pre-clinical drug candidate, MIRA1a.  The company’s current Report on Form 8-K unveils that what was previously believed to …